JETEMA

Wonju, South Korea Founded: 2009 • Age: 17 yrs Listed
Medical devices, drugs, and cosmetic products are manufactured by JETEMA.

About JETEMA

JETEMA is a publicly listed company based in Wonju (South Korea) founded in 2009. Medical devices, drugs, and cosmetic products are manufactured by JETEMA. The company has 243 employees. JETEMA offers products and services including Pharmaceutical Products and Medical Devices. Its focus areas include Traditional Medical Devices and Traditional Pharmaceuticals. Its legal entity is JETEMA, Co., Ltd.

Company details

JETEMA was founded in 2009 within the healthcare and cosmetics sectors. Medical devices, pharmaceutical drugs, and cosmetic products are developed and produced by the company. Operations encompass manufacturing processes tailored to regulatory standards in these fields. An online presence is maintained through the domain jetema.com. Emphasis is placed on core production activities without specified geographic details.

  • Headquarters Wonju, South Korea
  • Employees 243
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website jetema.com
  • Social Instagram YouTube
  • Legal Name Jetema Co., Ltd.
Key Metrics
  • Annual Revenue
    $53.25 M (USD)
    12.23
    as on Dec 31, 2025
  • Net Profit
    -$4.57 M (USD)
    -3407.38
    as on Dec 31, 2025
  • EBITDA
    $8.57 M (USD)
    -5.46
    as on Dec 31, 2025
  • Employee Count
    243

Products & Services of JETEMA

JETEMA offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Medical Devices.

Pharmaceutical Products
Healthcare

Innovative medicines are developed by JETEMA for health-related applications.

Medical Devices
Medical Technology

Medical devices are innovated by JETEMA to support a healthy lifestyle.

Apps and channels of JETEMA

its YouTube channel 제테마JETEMA has 336 subscribers and 30 videos.

제테마JETEMA
YouTube 336 subscribers 30 videos Education
Open channel

Videos from JETEMA

The most watched videos on JETEMA's YouTube channel, 제테마JETEMA (336 subscribers). Click a video to play it here.

[레나필] 나를 밝혀주는 필러, good morning_레나필
707.3K views
회사원 게임 | EP.2 "제발 그만해... 이러다 다 죽어!!!"
11.2K views
회사원 게임 | EP.1 "회사원 게임에 오신 여러분을 환영합니다"
4.2K views
🌍우주 최초!🌍 제테마 판교 신사옥을 공개합니다!!!
3.4K views

More on 제테마JETEMA.

People of JETEMA

3 people are tracked at JETEMA (3 in leadership); the tracked headcount is 243.

NameRoleGroup
Yoonkyoung Cha
Head Of Global Research & Development Division / 연구개발본부장/전무Leadership
Yoenhoi Heo
Development DirectorLeadership
Pablo Kim
General Manager / Head Of Int. Biz. & BD DivisionLeadership
Premium access

Complete people profiles for JETEMA

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of JETEMA

JETEMA is a publicly listed company on the KRX with ticker symbol 216080 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date14 Nov 2019
  • Listed onKRX: 216080
  • Listed entityJetema Co., Ltd.
  • Exchange sectorHealth technology
  • ISINKR7216080002
  • Share price5,960.00 KRW (+4.93% on the day) · 2026-10-14
  • Market capitalisation211,790,716,248.00 KRW
  • EPS (diluted, trailing year)-37.90 KRW
  • Volume (last session)87,561

Financials of JETEMA

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202576.90B KRW-6.60B KRW12.38B KRW
202468.52B KRW-188.2M KRW13.09B KRW
202358.72B KRW13.97B KRW11.01B KRW
202245.99B KRW1.46B KRW7.85B KRW
202133.22B KRW10.88B KRW5.65B KRW
Premium access

Detailed financial statements for JETEMA

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of JETEMA

The website of JETEMA (jetema.com) receives about 3.3K visits a month and ranks #3,516,104 among all websites worldwide, #4,555 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.3K

    ▼ 37.5% vs previous month

  • Unique visitors
    2.2K

    per month

  • Global rank
    #3,516,104

    among all websites

  • Category rank
    #4,555

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with JETEMA. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dermamall.co.kr
dermamall.co.kr
100%
#3,341,404–
directdermasupplies.com
directdermasupplies.com
93%
#2,781,127–
medisobizanews.com
65%
#283,693View details
medifonews.com
65%
#311,780View details
daechun.co.kr
daechun.co.kr
34%
#7,680,263–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for JETEMA

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jetema

Jetema Wins 15 Billion Won Order
Reuters β€’ 2 months ago
Jetema Wins 20 Billion Won Order
Reuters β€’ 10 months ago
Premium access

Complete news archive for JETEMA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JETEMA

JETEMA was founded in 2009.

JETEMA is headquartered in Wonju, South Korea. It is registered at Wonju, Gangwon, South Korea.

JETEMA has 243 employees.

Annual revenue of JETEMA is $53.25M as on Dec 31, 2025.

JETEMA was founded in 2009 within the healthcare and cosmetics sectors. Medical devices, pharmaceutical drugs, and cosmetic products are developed and produced by the company. Operations encompass manufacturing processes tailored to regulatory standards in these fields. An online presence is maintained through the domain jetema.com. Emphasis is placed on core production activities without specified geographic details.

JETEMA offers Pharmaceutical Products and Medical Devices.

Yes, JETEMA is publicly traded on KRX under the ticker symbol 216080.

JETEMA operates through Jetema, Co., Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available